Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher I Li

Showing results (121-130 of 276) with videos related to

Pageof 28
Sort By:
Breast Cancer Research and Treatment|March 29, 2022
Alcohol consumption, smoking, and invasive breast cancer risk after ductal carcinoma in situKristina M Jordahl, Kathleen E Malone, Michelle L Baglia, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 14, 2021
Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?Eman Biltaji, Brandon Walker, Trang H Au, et al.
JAMA|June 26, 2003
Relationship between long durations and different regimens of hormone therapy and risk of breast cancerChristopher I Li, Kathleen E Malone, Peggy L Porter, et al.
Annals of Epidemiology|February 28, 2012
Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancerAmanda I Phipps, Diana S M Buist, Kathleen E Malone, et al.
American Journal of Perinatology|February 7, 2019
Obstetric Outcomes in Young Women with Breast Cancer: Prior, Postpartum, and Subsequent PregnanciesKimberly K Ma, Courtney J Preusse, Philip A Stevenson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 21, 2012
Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer seraHailing Lu, Jon Ladd, Ziding Feng, et al.
Hormones & Cancer|July 25, 2012
Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancerAmanda I Phipps, Garnet L Anderson, Barbara B Cochrane, et al.
Scientific Reports|September 14, 2021
Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal massMatthew F Buas, Charles W Drescher, Nicole Urban, et al.
Breast Cancer Research and Treatment|February 25, 2014
Dermcidin expression is associated with disease progression and survival among breast cancer patientsHeather Ann Brauer, Monica D'Arcy, Tanya E Libby, et al.
American Journal of Epidemiology|October 23, 2009
Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer riskKerryn W Reding, Christopher I Li, Noel S Weiss, et al.
Pageof 28

Showing results (121-130 of 276) with videos related to

Sort By:
Pageof 28
Breast Cancer Research and Treatment|March 29, 2022
Alcohol consumption, smoking, and invasive breast cancer risk after ductal carcinoma in situKristina M Jordahl, Kathleen E Malone, Michelle L Baglia, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 14, 2021
Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?Eman Biltaji, Brandon Walker, Trang H Au, et al.
JAMA|June 26, 2003
Relationship between long durations and different regimens of hormone therapy and risk of breast cancerChristopher I Li, Kathleen E Malone, Peggy L Porter, et al.
Annals of Epidemiology|February 28, 2012
Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancerAmanda I Phipps, Diana S M Buist, Kathleen E Malone, et al.
American Journal of Perinatology|February 7, 2019
Obstetric Outcomes in Young Women with Breast Cancer: Prior, Postpartum, and Subsequent PregnanciesKimberly K Ma, Courtney J Preusse, Philip A Stevenson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 21, 2012
Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer seraHailing Lu, Jon Ladd, Ziding Feng, et al.
Hormones & Cancer|July 25, 2012
Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancerAmanda I Phipps, Garnet L Anderson, Barbara B Cochrane, et al.
Scientific Reports|September 14, 2021
Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal massMatthew F Buas, Charles W Drescher, Nicole Urban, et al.
Breast Cancer Research and Treatment|February 25, 2014
Dermcidin expression is associated with disease progression and survival among breast cancer patientsHeather Ann Brauer, Monica D'Arcy, Tanya E Libby, et al.
American Journal of Epidemiology|October 23, 2009
Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer riskKerryn W Reding, Christopher I Li, Noel S Weiss, et al.
Pageof 28